What is Indegene?
Founded in 1998 and headquartered in Bangalore, India, Indegene operates as a specialized technology-led healthcare solutions provider. The company distinguishes itself by synthesizing deep domain expertise with fit-for-purpose technology, enabling life sciences organizations to navigate the intricacies of drug commercialization and patient engagement. Its agile operating model is designed to support large-scale enterprise requirements, facilitating seamless integration across clinical, commercial, and medical affairs functions. By focusing on high-impact digital interventions, Indegene has established itself as a critical partner for global pharmaceutical and biotech firms seeking to optimize their operational efficiency and market reach.
How much funding has Indegene raised?
Indegene has raised a total of $200M across 1 funding round:
Stock Offering
$200M
Stock Issuance/Offering (2021): $200M with participation from Brighton Park Capital and The Carlyle Group
Key Investors in Indegene
Brighton Park Capital
A growth equity investment firm that partners with companies in the software, healthcare, and tech-enabled services sectors to drive long-term value.
The Carlyle Group
The Carlyle Group is a global investment firm specializing in private equity with operations across North America, Europe, Asia, Australia, the Middle East, Africa, and Latin America. Founded in 1987, the company manages numerous funds focused on four primary investment disciplines: buyouts, venture and growth capital, real estate, and leveraged finance.
What's next for Indegene?
Looking ahead, the strategic deployment of this capital will likely focus on expanding Indegene's technological infrastructure and deepening its footprint in key international markets. As the healthcare sector continues to prioritize digital-first strategies, the company is poised to scale its proprietary platforms to meet the growing demand for data-driven decision-making and personalized patient experiences. The backing from major institutional investors provides the necessary runway to pursue inorganic growth opportunities, potentially through targeted acquisitions that complement its existing service portfolio. By maintaining its focus on high-value, technology-enabled outcomes, Indegene is set to solidify its leadership in the enterprise healthcare services space, driving long-term value for its stakeholders and clients alike.
See full Indegene company page
